Pharma & Biotech
The posters were revealed Friday at the 2020 virtual annual meeting describing the 'compelling'...
TRACON Pharmaceuticals driving the development of targeted therapies for cancer
Orgenesis leads the charge at an exciting time for cell and gene therapy
BioPorto focused on flagship NGAL acute kidney-injury test but also looking at coronavirus test
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.